Q: Please interpret today's news release. Is this a B, S or H?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Could you recommend 1 Biotech and 1 Fintech ETF? Can be either Canadian or US.
Thanks for your help
Thanks for your help
Q: Could I get your opinion on Kneat (KSI), its balance sheet, valuation, headwinds/tailwinds and competitors?
Thanks for your great advice.
Thanks for your great advice.
Q: Morning 5iTeam,
I would appreciate your comments on nstg going forward and would you consider it a buy, sell or hold now.
Cheers,
H
I would appreciate your comments on nstg going forward and would you consider it a buy, sell or hold now.
Cheers,
H
-
Regeneron Pharmaceuticals Inc. (REGN $796.55)
-
AbbVie Inc. (ABBV $220.08)
-
Medtronic plc. (MDT $97.53)
-
Stryker Corporation (SYK $367.54)
-
Zimmer Biomet Holdings Inc. (ZBH $92.85)
Q: According to portfolio analytics I need to increase my allocation to healthcare.
Have MRK. Please rank the following from 1. growth perspective 2. safety perspective: MDT SYK ABBV ZBH REGN
Have MRK. Please rank the following from 1. growth perspective 2. safety perspective: MDT SYK ABBV ZBH REGN
-
Intuitive Surgical Inc. (ISRG $586.24)
-
AbbVie Inc. (ABBV $220.08)
-
Bristol-Myers Squibb Company (BMY $55.86)
-
CVS Health Corporation (CVS $80.30)
-
Merck & Company Inc. (MRK $110.53)
-
GSK plc American Depositary Shares (Each representing two) (GSK $50.39)
Q: As a new subscriber, I’m thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.
I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?
I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?
Q: Hi guys, what do you think about this company for the long term? Thank you
Q: InMode has dropped significantly over the past month, would you see this as a buying opportunity or is it too risky?
-
CVS Health Corporation (CVS $80.30)
-
Quest Diagnostics Incorporated (DGX $174.44)
-
Medtronic plc. (MDT $97.53)
Q: I need to increase the healthcare allocation in my portfolio. I am considering MDT, DGX,and CVS as, I think, together they provide a good balance of strong fundamentals, yield and some growth. Do you agree, and do you have any other (non-pharma) suggestions.
Many Thanks
John
Many Thanks
John
Q: Hello, XENE
Any info on this company? Doesn't appear to come up on the questions or the company profile sections of the 5i website. How would you approach investing in this company, if at all?
Any info on this company? Doesn't appear to come up on the questions or the company profile sections of the 5i website. How would you approach investing in this company, if at all?
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $71.85)
-
Harvest Healthcare Leaders Income ETF (HHL.U $8.66)
Q: Hi guys
I am a steady eady dividend investor and have almost no healthcare exposure. I am looking to buy a ETF that gives me an exposure to the various healthcare sectors (not just pharmaceuticals), I am looking at overall growth for the units - capital gains and dividends - not just dividends. Wondering what your best ETF ideas would be for this sector. I saw Harvest Healthcare leaders recommended by Gordon Pape - don't know if you have some thoughts on that one - eg. how they squeeze such a high dividend out of it?
Thanks
stuart
I am a steady eady dividend investor and have almost no healthcare exposure. I am looking to buy a ETF that gives me an exposure to the various healthcare sectors (not just pharmaceuticals), I am looking at overall growth for the units - capital gains and dividends - not just dividends. Wondering what your best ETF ideas would be for this sector. I saw Harvest Healthcare leaders recommended by Gordon Pape - don't know if you have some thoughts on that one - eg. how they squeeze such a high dividend out of it?
Thanks
stuart
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $71.85)
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $72.18)
-
Harvest Healthcare Leaders Income ETF (HHL $7.89)
Q: I own ZUH and XHC and am thinking of selling them to buy HHL for the big dividend that HHL pays (8.61%) . Is this a good idea? Or am I trading growth potential for dividends and could I actually be making a mistake?
Q: Can you comment on the drop in price. Is it a sell or hold. Thanks
Q: Good morning, Peter and Co.
I currently hold ABBV in a portfolio. With its upcoming patent issues is their a stock you would recommend as a replacement or would you recommend I retain it for a long yerm hold?
With appreciation,
Ed
I currently hold ABBV in a portfolio. With its upcoming patent issues is their a stock you would recommend as a replacement or would you recommend I retain it for a long yerm hold?
With appreciation,
Ed
Q: I have be holding Carebook stock for over six months. The stock dipped over the past week and bit from 79 cents to 60 cents, but I cannot seem to find a driver for the news. Am I missing something? Is it a good time to buy more? iA Capital Markets just put a 'Buy' recommendation on it with a $1.60 target due to some new acquisition and other moves, but the stock has been tanking. Again, what am I missing?
Thanks in advance!
Thanks in advance!
Q: As retirees with moderate risk tolerance, Telus is a 4% core holding in a mainly conservative dividend portfolio. We realize (and like) that Telus Health is a small part of the company. We are considering a 1% position in Well for diversification in Health sector, and would appreciate your thoughts on it. Is this an opportune time to buy, or does 5i expect tax loss selling to put more downward pressure as year-end approaches? Thank you. Edward
-
Profound Medical Corp. (PRN $11.71)
-
Arch Biopartners Inc. (ARCH $1.32)
-
Medicenna Therapeutics Corp. (MDNA $0.94)
Q: What are your top three picks in the Canadian Biotechnolgy sector, and what do you like about them.
Thanks!
Thanks!
-
Illumina Inc. (ILMN $141.07)
-
Intuitive Surgical Inc. (ISRG $586.24)
-
Regeneron Pharmaceuticals Inc. (REGN $796.55)
-
AbbVie Inc. (ABBV $220.08)
-
Profound Medical Corp. (PRN $11.71)
-
iShares Biotechnology ETF (IBB $172.39)
-
Guardant Health Inc. (GH $110.17)
-
ARK Genomic Revolution ETF (ARKG $30.55)
Q: I recently took profits in IBB and ARKG. I like the sector but would prefer a more focused approach. What are your 5 best biotech stocks for a long term hold. Thanks for this great service. I tell everyone that the best value around is a 5i membership.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $71.85)
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $72.18)
-
Harvest Healthcare Leaders Income ETF (HHL $7.89)
-
First Trust AlphaDEX U.S. Health Care Sector Index ETF (FHH $43.90)
Q: Are there Healthcare ETF's in Canada and in the U.S. that you might recommend? Thank you.
Q: Following Merck's COVID-19 Pill Success, Novavax is down quite a bit, do you think right now is a good entry point to initiate a position? Thank you!